Clinical Trial Grant - Cannonball Kids' cancer Foundation
Forecasted
Clinical Trial Grant - Cannonball Kids' cancer Foundation supports researchers developing innovative pediatric cancer trials to expand treatment options, improve quality of life, and relieve symptoms.
Browse similar grants
Funder: Cannonball Kids' cancer Foundation
Due Dates (Anticipated): June 2027 (LOI) | September 2027 (Application)
Funding Amounts: Up to $200,000 over 3 years
Summary: Supports innovative pediatric cancer clinical trials that improve quality of life, relieve symptoms, or expand treatment options.
Key Information: Principal investigators must hold an academic appointment at Assistant Professor level or higher, and preclinical studies must be complete.
Description
Cannonball Kids' cancer Foundation (CKc) funds innovative, first-of-its-kind pediatric cancer research so children can not only survive a cancer diagnosis but thrive afterward. Its Clinical Trial Grant supports novel treatments or methods that offer better quality of life or symptom relief than current treatments. Innovation may include fewer side effects, improved quality of life, or care options where few or none exist at initial diagnosis, relapse, or for recalcitrant cancers.
CKc prioritizes clinical trials and research nearing translation into a clinical trial. Whenever possible, it favors research addressing underfunded or under-researched cancers, traditionally underserved patient populations, and researchers from diverse backgrounds. Clinical Trial proposals are also evaluated for the number of treatment options they would provide and their accessibility to children and families.
